Heated tension between state and federal AI regulators is coming, predict two attorneys subspecialized in AI startup success, data privacy and cybersecurity.
The Amend device from Valcare Medical has a closed ring shape similar to the annuloplasty rings used to treat MR during open-heart surgeries. These early patients will be followed for a total of five years.
A growing chorus of academic physicians, policy experts and public health specialists is harmonizing behind the idea of licensing medical GenAI models like they’re doctors or nurses.
Researchers explored data from more than 1,000 patients with calcified coronary artery disease who required plaque modification. IVL and atherectomy were linked to comparable success rates, but adverse events were less likely with IVL.
Cardiac complications after noncardiac surgeries are a significant concern, especially as patients keep living longer and surgical volumes continue to rise.
The federal government recently released new data pertaining to the landmark legislation, meant to protect patients from receiving unexpected medical bills.
Dynocardia has now received nearly $5.1 million in funding from the NHLBI to help speed commercializing its wrist-worn monitor to avoid the need for invasive catheter BP monitoring.
The objective of the AHA scientific statement is to review the available evidence on for better management of cardiac arrhythmias from COVID causes that are still encountered on a regular basis.
Such technology can be leveraged to improve risk assessments without accruing additional expenses for patients or clinicians, potentially filling in gaps where DXA exams fall short.
Konica Minolta Healthcare is introducing Exa Enterprise, a new enterprise imaging solution that encompasses the Exa PACS-RIS core powered by AWS’s proven cloud solution and its data. This new enterprise cloud solution will deliver exceptionally fast access to data and boost efficiency across imaging specialties.
Heated tension between state and federal AI regulators is coming, predict two attorneys subspecialized in AI startup success, data privacy and cybersecurity.
![The use of intravascular lithotripsy (IVL) during percutaneous coronary intervention (PCI) is still safe and effective when patients present with calcified nodules (CNs), according to new long-term data published in EuroIntervention.[1] Researchers compared outcomes from patients with and without CNs, highlighting key similarities in stent expansion and luminal gain.](/sites/default/files/styles/stack_views/public/2024-12/screenshot_2024-12-02_at_11.07.21_am.png.webp?itok=WCWcIaTj)
